Trials / Conditions / FIGO Stage III Ovarian Cancer 2014
FIGO Stage III Ovarian Cancer 2014
3 registered clinical trials studyying FIGO Stage III Ovarian Cancer 2014 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314 | NRG Oncology | Phase 3 |
| Recruiting | Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV O NCT06639074 | Mayo Clinic | Phase 2 |
| Completed | Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, NCT02713386 | NRG Oncology | Phase 1 / Phase 2 |